Journal of Cachexia, Sarcopenia and Muscle (JCSM) - Abstract


Volume 5, Number 4, Page 287 - 296

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones

Krystian Josiak, Ewa A. Jankowska, Massimo F. Piepoli, Waldemar Banasiak, Piotr Ponikowski

In heart failure, impairment of cardiac muscle function leads to numerous neurohormonal and metabolic disorders, including an imbalance between anabolic and catabolic processes, in favour of the latter. These disorders cause loss of muscle mass with structural and functional changes within the skeletal muscles, known as skeletal myopathy. This phenomenon constitutes an important mechanism that participates in the pathogenesis of chronic heart failure. both its clinical symptoms and the progression of the disease. Attempts to reverse the above-mentioned pathologic processes by exploiting the anabolic action of androgenic hormones could provide a potentially attractive treatment option. The current concepts of anabolic androgen deficiency and resultant skeletal myopathy in patients with heart failure are reviewed, and the potential role of anabolic-androgenic hormones as an emerging therapeutic option for targeting heart failure is discussed.

Josiak K., Jankowska E.A., Piepoli M.F., Banasiak W., Ponikowski P., Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J Cachex Sarcopenia Muscle 2014;4:287-296.